Form 4: Integral Ad Science Executive Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


An Integral Ad Science executive sold 721 shares of common stock to cover tax liabilities related to the settlement of restricted stock units.

Summary

  • Alexis Gil II, Chief Accounting Officer of Integral Ad Science Holding Corp., sold 721 shares of common stock on January 3, 2025.
  • The sale was executed to cover tax liabilities associated with the settlement of restricted stock units.
  • The shares were sold at a weighted average price of $10.69, with individual transactions ranging from $10.65 to $10.75 per share.
  • Following the transaction, Mr. Gil directly owns 122,409 shares of Integral Ad Science Holding Corp.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction for tax purposes, which is neither positive nor negative for the company's overall performance. The sentiment is neutral to slightly positive as it indicates the executive is receiving stock-based compensation.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

  • Executive stock sales to cover tax liabilities are a common practice across publicly traded companies.
  • The sale of 721 shares is relatively small compared to the total holdings of 122,409 shares, suggesting this is a routine tax-related transaction rather than a significant change in the executive's investment position.
  • Similar transactions are regularly reported by executives at other tech companies, such as Google, Meta, and Amazon, when their stock options or restricted stock units vest.

Stakeholder Impact

  • The transaction has a minimal impact on shareholders as it is a small sale by an executive for tax purposes.

Key Dates

DateDescription
01/03/2025Date of the stock sale transaction.
01/07/2025Date the Form 4 was signed.

Keywords

Integral Ad Science, IAS, stock sale, executive, Form 4, restricted stock units, tax liability, insider trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.